関連文献

Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease.

JCI Insight. 2025. doi: 10.1172/jci.insight.179362.PubMed

Evaluation of Serum L-FABP as a Biomarker and Hepatoprotective Effect of L-FABP Using Wild-Type and Human L-FABP Chromosome Transgenic Mice.

J Am Assoc Lab Anim Sci. 2025. doi: 10.30802/AALAS-JAALAS-25-003.PubMed

Urinary L-FABP: A Novel Biomarker for Evaluating Diabetic Nephropathy Onset and Progression. A Narrative Review.

Diabetes Ther. 2025. doi: 10.1007/s13300-025-01731-w.PubMed

Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy.

BMC Nephrol. 2025. doi: 10.1186/s12882-025-04049-8.PubMed

Estimated Proximal Tubule Fluid Phosphate Concentration and Renal Tubular Damage Biomarkers in Early Stages of Chronic Kidney Disease.

J Ren Nutr. 2024.doi: 10.1053/j.jrn.2024.06.009.PubMed

Topiroxostat-A Safer Uricostatic Drug with Enhanced Renal Protection: A Narrative Review.

J Assoc Physicians India. 2024doi: 10.59556/japi.72.0724.PubMed

Diagnostic Accuracy of L-FABP-to-Creatinine Ratio (LCR) for Prediction of Kidney Damage in Type-2 DM Patients Taking Albumin-to-Creatinine Ratio (ACR) as Gold Standard.

J Pak Soc Intern Med. 2024.doi: jpsim.v5i4.2465JPSIM

Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.

Biomedicines. 2024doi: 10.3390/biomedicines12081789.PubMed

Estimated proximal tubule fluid phosphate concentration and renal tubular damage biomarkers in early stages of chronic kidney disease.

J Ren Nutr. 2024doi: 10.1053/j.jrn.2024.06.009.PubMed

Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study.

J Clin Med. 2024doi: 10.3390/jcm13030736.PubMed